Study of CBP-4888 for preterm preeclampsia in hospitals
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and pregnant.
- You are between 26 weeks and 35 weeks 6 days pregnant with one baby.
- You have been hospitalized for preeclampsia (high blood pressure with protein in urine or signs of organ problems).
- Your doctors expect you to stay in the hospital until delivery.
- You and your baby are stable enough to wait at least 72 hours after the medicine is given.
- You do not have certain other pregnancy problems or severe health conditions (like severe high blood pressure, kidney disease, or active infections).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This study looks at the placenta and the area where the baby meets the mother's body to understand preeclampsia, a serious pregnancy complication. If you are between 9 and 15 weeks pregnant with one baby and are already scheduled for a placenta test, you may be able to join.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.